TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
ImmuNeed AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
12,567
|
20,161
|
20,951 |
| Financial expenses |
152
|
149
|
51 |
| Earnings before taxes |
-8,517
|
-9,478
|
-7,123 |
| EBITDA |
-8,025
|
-8,946
|
-6,676 |
| Total assets |
10,160
|
14,020
|
10,407 |
| Current assets |
8,938
|
12,495
|
8,696 |
| Current liabilities |
4,986
|
7,962
|
7,097 |
| Equity capital |
4,680
|
5,122
|
2,456 |
| - share capital |
293
|
281
|
192 |
| Employees (average) |
10
|
15
|
14 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
46.1%
|
36.5%
|
23.6% |
| Turnover per employee |
1,257
|
1,344
|
1,496 |
| Profit as a percentage of turnover |
-67.8%
|
-47.0%
|
-34.0% |
| Return on assets (ROA) |
-82.3%
|
-66.5%
|
-68.0% |
| Current ratio |
179.3%
|
156.9%
|
122.5% |
| Return on equity (ROE) |
-182.0%
|
-185.0%
|
-290.0% |
| Change turnover |
-7,957
|
-2,276
|
8,695 |
| Change turnover % |
-39%
|
-10%
|
71% |
| Chg. No. of employees |
-5
|
1
|
4 |
| Chg. No. of employees % |
-33%
|
7%
|
40% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.